Policy Archives | Page 3 of 16

Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.

by Marci A. Landsmann

Medicaid: A Partial Safety Net

Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.

by Sharon Tregaskis

Forward Look

Adequate Representation

Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

by Erin O'Donnell

Policy Matters

Cancer Research: The Key to Tomorrow’s Cures

The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.

by David A. Tuveson, MD, PhD

Facts and Stats

Fifty Years of Growing Survivorship

More people in the U.S. are alive after being diagnosed with cancer than ever before.

by Eric Fitzsimmons

From the Editor-in-Chief

Improving Clinical Trials

The fast pace of drug discovery should be matched by modernized clinical trials for wider access.

by William G. Nelson, MD, PhD

Oncology Takes on Cannabis

People take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.

by Kate Yandell

Policy Matters

The FDA Takes Steps to Curb Tobacco Use

The federal agency wants to ban menthol-flavored cigarettes, ban all flavors of cigars, and limit nicotine content.

by Nicholas Warren, PhD

Preconceived Notions: Cancer, Fertility Coverage and the Law

Insurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.

by Shelly Rosenfeld